-
$300,000,000 
Blue Sage Capital III, L.P. September 2020South and Midwest
U.S. Lower Middle-Market
Buyout
-
$821,785,000 
B Capital Fund II, L.P. June 2020Global Technology-Enabled
Venture Growth -
$1,104,349,000 
CRG Partners IV L.P. April 2020Private Debt
in Commercial-Stage
Healthcare Companies
-
Riverside Capital Appreciation Fund VII, L.P. November 2019U.S. Lower Middle-Market
Buyout
-
$1,430,000,000 
Vivo Capital Fund IX October 2019Cross-Border
Healthcare Investing
Across Stage
-
€255,250,000 
Alma Property
Partners II ABSeptember 2019Nordic Value Add /
Opportunistic Real Estate
-
$2,000,000,000 
Centurium Capital
Partners 2018, L.P.July 2019China Mid-Market
Buyout and Significant
Minority Growth Equity
-
$4,300,000,000 
WCAS XIII, L.P. July 2019U.S. Middle-Market
Technology and
Healthcare Buyout
-
$300,000,000 
Forebright New Opportunities Fund II L.P. June 2019China Middle-Market
Growth Private Equity
-
$266,300,000 
Hidden Harbor Capital Partners I, L.P. January 2019Value-Oriented
Lower Middle-Market
Buyout
-
$149,000,000 
Blue Lake Capital
Fund IIDecember 2018China Early Stage
TMT Venture Capital
-
$224,387,755 
Black Bay Energy, L.P. June 2018Lower Middle-Market
Oilfield Services
-
$447,175,000 
Avenue Asia Special
Situations Fund V, L.P.June 2018Pan-Asia
Credit and
Special Situations
-
$3,014,980,000 
CVI Credit Value
Fund IV, L.P.April 2018Global Opportunistic
Credit Fund
-
€345,000,000 
Andera BioDiscovery
5 FPCIFebruary 2018European
Venture Capital
Life Sciences
-
$1,451,282,053 
Wellspring Capital Partners VI, L.P. January 2018Value-Oriented
Middle-Market
Buyout
-
$636,340,001 
Calmwater Capital U.S. Real Estate Credit Fund III, LP December 2017Lower Middle-Market
Commercial Real Estate
Lending
-
$687,000,000 
Hammes Partners III, L.P. December 2017U.S. Healthcare
Real Estate
-
$177,600,000 
Arrowroot Capital III, L.P. November 2017Software Growth Equity
-
€690,000,000 
Clareant Strategic Credit Fund, L.P. August 2017European Stressed, Distressed, and Structured Debt